标题: |
子宫内膜癌MDT临床实践中国专家共识(2023) |
title: |
Chinese multidisciplinary consensus on the clinical management of patients with endometrial cancer |
版本: |
原创版 |
version: |
Original |
分类: |
专家共识 |
classification: |
Experts consensus |
领域: |
综合 |
field: |
Comprehensive guideline |
国家和地区: |
中国 |
Country and
region:
|
China |
指南使用者: |
妇科肿瘤MDT团队成员 |
Guide users:
|
Members in Gynecologic Oncology multidisciplinary team |
证据分级方法: |
证据级别
1类 III期随机对照临床试验和/或meta分析
2类 前瞻性的临床研究或小型随机对照临床试验
3类 Case report或广泛的临床经验
|
Evidence grading
method:
|
Level of Evidence
Category 1 Phase III randomized controlled clinical trial and/or meta-analysis
Category 2 Prospective clinical studies or small randomized controlled clinical trials
Category 3 Case report or extensive clinical experience |
制定单位: |
中国医师协会妇产科分会妇科肿瘤专业委员会 |
Formulating unit: |
The Society of Gynecological Cancer of China Anti-Cancer Association |
注册时间: |
2023-05-11 |
Registration time: |
注册编号: |
PREPARE-2023CN329 |
Registration number: |
指南制订的目的: |
对子宫内膜癌临床实践中的复杂、疑难且需要多学科决策的问题进行证据总结及跨学科意见汇总,为子宫内膜癌MDT提供支持,推动中国子宫内膜癌患者标准治疗基础上的个体化诊疗 |
Purpose of the guideline:
|
Summarize the evidence and interdisciplinary opinions on complex or challenging issues requiring multidisciplinary decision-making in endometrial cancer.
Support MDT team to improve individualized treatment for endometrial cancer patients in China |